Erasca, Inc. - 8-K Filing
Erasca announced updated preliminary Phase 1 data for ERAS-0015 in RAS-mutant solid tumors and plans to initiate registration-enabling trials. (Items: 8.01 Other Events)
Tickers: $ERAS
Erasca announced updated preliminary Phase 1 data for ERAS-0015 in RAS-mutant solid tumors and plans to initiate registration-enabling trials. (Items: 8.01 Other Events)
Tickers: $ERAS